With the analysis among 32 patents, we discovered top 18 key players by total patent application. Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd., Yantai Dongcheng Pharmaceutical Group Co., Ltd., Hubei Enoray Biopharmaceutical Co. Ltd. are dominant in this area. They take 37.50% of the total patent filing.
Guangdong Sheng, China
Patent: 5
Shandong Sheng, China
Patent: 4
Hubei Sheng, China
Patent: 3
Hebei Sheng, China
Patent: 2
Jiangsu Sheng, China
Patent: 2
Jiangsu Sheng, China
Patent: 2
Jiangsu Sheng, China
Patent: 2
Jiangsu Sheng, China
Patent: 2
Shandong Sheng, China
Patent: 1
Beijing Shi, China
Patent: 1
No data, please try another search term
With the analysis among related 14 patents applied in the last 5 years. We discover 9 most active companies in this area. The fast-growing Hubei Enoray Biopharmaceutical Co. Ltd., Yantai Dongcheng Pharmaceutical Group Co., Ltd., Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd. take 42.86% of patent filing during this period.
Hubei Sheng, China
Patent: 2
Shandong Sheng, China
Patent: 2
Guangdong Sheng, China
Patent: 2
Jiangsu Sheng, China
Patent: 1
Beijing Shi, China
Patent: 1
Hunan Sheng, China
Patent: 1
Hebei Sheng, China
Patent: 1
Jiangsu Sheng, China
Patent: 1
Tianjin Shi, China
Patent: 1
With the analysis among related 14 patents in last 5 years, we discover 4 new entrants. Wuxi Galek Chromatography Technology Co., Ltd., Beijing Science Sun Pharmaceutical Co., Ltd., Xiangya Hospital of Central South University are the most active new entrants in this area.
Jiangsu Sheng, China
Patent: 1
Beijing Shi, China
Patent: 1
Hunan Sheng, China
Patent: 1
Tianjin Shi, China
Patent: 1
No data, please try another search term